We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
(+27%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$99.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$98.7M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$96.7M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$90.3M |
| 5 |
RTX Corp
RTX
|
+$82.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$122M |
| 2 |
Alibaba
BABA
|
+$107M |
| 3 |
Quest Diagnostics
DGX
|
+$107M |
| 4 |
Pfizer
PFE
|
+$88.9M |
| 5 |
Walt Disney
DIS
|
+$88.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Norfolk Southern
NSC
$75.4B
| $77.9M | 0.27% |
443,648
+948
| +0.2% | +$161K |
|
102
FirstEnergy
FE
$28.4B
| $77.2M | 0.27% |
1,991,232
+8,661
| +0.4% | +$358K |
|
|
EVBG
103
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $77.1M | 0.27% |
557,554
+159,077
| +40% | +$20.7M |
|
104
Oneok
OKE
$56.4B
| $76M | 0.27% |
2,288,636
-156,619
| -6% | -$5.1M |
|
|
AVLR
105
DELISTED
Avalara, Inc.
AVLR
| $75.4M | 0.26% |
566,650
+132,576
| +31% | +$13M |
|
106
Amgen
AMGN
$209B
| $75.2M | 0.26% |
318,915
-67,352
| -17% | -$15.4M |
|
107
Rockwell Automation
ROK
$50.9B
| $74.6M | 0.26% |
+350,457
| New | +$67.8M |
|
108
Crown Castle
CCI
$34.4B
| $74.5M | 0.26% |
445,066
+71,800
| +19% | +$11.6M |
|
109
Sysco
SYY
$41B
| $74.3M | 0.26% |
1,359,356
+57,379
| +4% | +$3.02M |
|
|
MRTX
110
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $74.1M | 0.26% |
649,455
-20,810
| -3% | -$2.02M |
|
|
NVRO
111
DELISTED
NEVRO CORP.
NVRO
| $73.9M | 0.26% |
618,541
-156,475
| -20% | -$18.6M |
|
112
Cummins
CMI
$83.8B
| $73.1M | 0.26% |
422,099
-289,983
| -41% | -$46.3M |
|
113
Trex
TREX
$4.4B
| $72.3M | 0.25% |
1,111,226
+531,064
| +92% | +$28.3M |
|
114
McDonald's
MCD
$193B
| $70.5M | 0.25% |
382,200
+28,900
| +8% | +$5.3M |
|
115
Edison International
EIX
$30.3B
| $70.2M | 0.25% |
1,291,894
-806,098
| -38% | -$46.4M |
|
116
AT&T
T
$165B
| $70M | 0.24% |
3,065,522
-2,148,550
| -41% | -$48.9M |
|
117
General Mills
GIS
$20.2B
| $69.2M | 0.24% |
1,123,128
-1,402,480
| -56% | -$84.6M |
|
118
Advanced Micro Devices
AMD
$706B
| $68.5M | 0.24% |
1,302,726
-214,704
| -14% | -$11.4M |
|
119
Alcon
ALC
$33.9B
| $68M | 0.24% |
+1,185,654
| New | +$67.1M |
|
120
General Dynamics
GD
$104B
| $67.9M | 0.24% |
454,516
+32,028
| +8% | +$4.52M |
|
121
AstraZeneca
AZN
$268B
| $67.7M | 0.24% |
639,564
+626,132
| +4,661% | +$64.7M |
|
122
Accenture
ACN
$106B
| $66.5M | 0.23% |
309,891
+93,900
| +43% | +$17.8M |
|
123
RenaissanceRe
RNR
$13.8B
| $66.5M | 0.23% |
389,047
+2,284
| +0.6% | +$375K |
|
124
Landstar System
LSTR
$6.02B
| $66.4M | 0.23% |
591,542
-14,590
| -2% | -$1.56M |
|
125
Jack Henry & Associates
JKHY
$11.5B
| $66.1M | 0.23% |
359,355
+193,030
| +116% | +$33.6M |
|
Similar funds
Lord, Abbett & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.
- Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
- Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
- Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
- Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
- Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
- Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
- Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.
Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.